$ARWR why are there so many idiots here? Yes, it’s a massive move because it’s a RERATE. The street is saying, you know what, we were wrong on our valuation and the price is now reflective of the new reality. The $MDCO deal gave price discovery for what I believe is the best RNAi platform and (best run business model). Take some off the table if you want (I have) depending on how you want to be balanced and manage risk, but ARWR has a long way to go before it’s a mature pharma. Very few companies make the leap, but remember, Amgen was a small company once too.